A chimeric murine MSLN-VLP has been shown to break the tolerance to the murine MSLN self-antigen, as well as reduce tumor growth and prolong overall survival in an orthotopic pancreatic cancer model [107]. The gene discussed is MSLN; the disease is familial pancreatic carcinoma.